Novo Nordisk A/S
NYSE:NVO
Novo Nordisk A/S
Operating Income
Novo Nordisk A/S
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novo Nordisk A/S
CSE:NOVO B
|
Operating Income
kr104.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
H Lundbeck A/S
CSE:HLUN A
|
Operating Income
kr3.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ALK-Abello A/S
CSE:ALK B
|
Operating Income
kr666m
|
CAGR 3-Years
64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Operating Income?
Operating Income
104.7B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Operating Income amounts to 104.7B DKK.
What is Novo Nordisk A/S's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was 38%. The average annual Operating Income growth rates for Novo Nordisk A/S have been 24% over the past three years , 17% over the past five years , and 13% over the past ten years .